KIDS vs. ATRI, CSII, OSUR, CERS, TCMD, NARI, IRTC, NVCR, ICUI, and IART
Should you be buying OrthoPediatrics stock or one of its competitors? The main competitors of OrthoPediatrics include Atrion (ATRI), Cardiovascular Systems (CSII), OraSure Technologies (OSUR), Cerus (CERS), Tactile Systems Technology (TCMD), Inari Medical (NARI), iRhythm Technologies (IRTC), NovoCure (NVCR), ICU Medical (ICUI), and Integra LifeSciences (IART). These companies are all part of the "surgical & medical instruments" industry.
Atrion (NASDAQ:ATRI) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, media sentiment, community ranking, profitability and institutional ownership.
Atrion has a net margin of 10.60% compared to Atrion's net margin of -13.58%. OrthoPediatrics' return on equity of 7.75% beat Atrion's return on equity.
OrthoPediatrics has a consensus price target of $45.50, indicating a potential upside of 44.08%. Given Atrion's higher possible upside, analysts clearly believe OrthoPediatrics is more favorable than Atrion.
66.2% of Atrion shares are held by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are held by institutional investors. 22.8% of Atrion shares are held by insiders. Comparatively, 31.8% of OrthoPediatrics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Atrion has a beta of 0.62, suggesting that its share price is 38% less volatile than the S&P 500. Comparatively, OrthoPediatrics has a beta of 1.16, suggesting that its share price is 16% more volatile than the S&P 500.
Atrion has higher revenue and earnings than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Atrion, indicating that it is currently the more affordable of the two stocks.
OrthoPediatrics received 177 more outperform votes than Atrion when rated by MarketBeat users. Likewise, 64.56% of users gave OrthoPediatrics an outperform vote while only 54.89% of users gave Atrion an outperform vote.
In the previous week, Atrion had 9 more articles in the media than OrthoPediatrics. MarketBeat recorded 11 mentions for Atrion and 2 mentions for OrthoPediatrics. Atrion's average media sentiment score of 1.87 beat OrthoPediatrics' score of 0.22 indicating that OrthoPediatrics is being referred to more favorably in the news media.
Summary
OrthoPediatrics beats Atrion on 9 of the 17 factors compared between the two stocks.
Get OrthoPediatrics News Delivered to You Automatically
Sign up to receive the latest news and ratings for KIDS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding KIDS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
OrthoPediatrics Competitors List
Related Companies and Tools
